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Abstract Pleckstrin homology (PH) domains are protein
modules found in proteins involved in many cellular processes.
The majority of PH domain-containing proteins require mem-
brane association for their function. It has been shown that most
PH domains interact directly with the cell membrane by binding
to phosphoinositides with a broad range of specificity and
affinity. While a highly specific binding of the PH domain to a
phosphoinositide can be necessary and sufficient for the correct
recruitment of the host protein to the membrane, a weaker and
less specific interaction may be necessary but not sufficient,
thus probably requiring alternative, co-operative mech-
anisms. ß 2001 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
The pleckstrin homology (PH) domain is a structural pro-
tein module of approximately 100 amino acid residues that
was ¢rst identi¢ed in 1993, occurring twice in pleckstrin, the
major protein kinase C substrate in platelets [1,2]. It is found
in a large variety of proteins involved in cellular signaling,
cytoskeletal organisation, regulation of intracellular mem-
brane transport and modi¢cation of membrane phospholipids
[3,4]. Several PH domain structures have been solved by nu-
clear magnetic resonance and X-ray crystallography, showing
that, despite their poorly conserved primary structures, they
retain a highly conserved three-dimensional organisation (Fig.
1). The core structure is a L-sandwich of two nearly orthog-
onal L-sheets consisting of three and four strands, respec-
tively. The L-sheets are closely packed, in particular at the
so-called close corners, one of which is spanned by strand
L1 while the other is completed by a loop connecting strands
L4 and L5. There are six loops connecting the L-strands. Three
of these (L1/L2, L3/L4 and L6/L7) have been termed ‘variable
loops’, showing hypervariable sequences in early alignments
of PH domains. The opposite edge of the structure is capped
by the amphipathic C-terminal K-helix. These two latter re-
gions are termed ‘splayed corners’ and are responsible for the
polarisation of the PH domain; one side of the domain, in-
cluding the variable loops, is a positively charged surface,
made of lysines, arginines and histidines, while the opposite
face, including the K-helix, is enriched in acidic residues. The
majority of PH domain-containing proteins appear to have a
functional requirement to be membrane-associated [5] and
several studies indicate that PH domains function as mem-
brane adapters or tethers, linking their host proteins to the
membrane surface. The identity of the ligands responsible for
membrane binding is often controversial.
2. PH domain as a protein binding domain
When it was identi¢ed, the PH domain was thought to be a
protein binding domain. Many di¡erent protein ligands were
suggested although a general protein target for the PH do-
main, as shown for the SH2 and SH3 domains, was not iden-
ti¢ed. The ¢rst candidates were the LQ subunits of heterotri-
meric G proteins that were shown to be the targets of the PH
domains of L-adrenergic receptor kinase (L-ARK) [6] and
Bruton’s tyrosine kinase (Btk) [7]. In particular, the C-termi-
nal region of the L-ARK PH domain was shown to interact
with a region of GL, built up from seven repeats of 40 amino
acids containing the dipeptide Trp-Asp and known as WD40
repeat [8,9]. This result, together with the observation that the
L-ARK PH domain and those of the src-related tyrosine ki-
nase TecIIa and the GTPase dynamin could bind another
WD40-containing protein, the Lis1 gene product [10], gave
rise to the concept that binding to WD40 motifs was a general
feature of PH domains. Further evidence for a protein^pro-
tein interaction mediated by the PH domain has been pub-
lished more recently. By using a yeast two-hybrid system, it
has been shown, for instance, that the PH domains of insulin
receptor substrate (IRS) 1 and 2 can bind to proteins contain-
ing acidic amino acid residues, such as nucleolin [11]. This
interaction is likely to be very speci¢c since some other PH
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domains tested do not bind nucleolin; in particular, the PH
domain of IRS-1 seems to be more selective since other pro-
teins containing acidic motifs bind to IRS-2 but not IRS-1.
These results support the hypothesis that the PH domain in
IRS proteins may target the host protein to membranes by
binding to acidic peptide motifs or other components in mem-
branes. Further yeast two-hybrid screening has revealed the
existence of an interaction between the PH domain of IRS-1
and a novel protein, termed PHIP (PH-interacting protein)
[12]. This protein selectively binds to the PH domain of
IRS-1 in vitro, associates with IRS-1 in vivo, and may func-
tion to link IRS-1 to the insulin receptor. This interaction
requires an intact PH fold since mutants of the PH domain
that disrupt the PH fold do not bind PHIP.
Several PH domains, as glutathione S-transferase fusion
proteins or as isolated polypeptides, have been shown to
bind to ¢lamentous actin and induce an actin bundle forma-
tion. In particular, a short stretch of basic amino acids in the
¢rst L-sheet of the Btk PH domain is involved in this inter-
action although actin binding does not seem to be de¢ned
solely by these basic residues [13].
Very recently, an interaction has been described between
the PH domain of Etk (a member of the Btk family of tyro-
sine kinases) and the FERM domain of FAK, which in turn
regulates the activation of Etk by extracellular matrix proteins
[14]. These data suggest a role for PH domain interactions in
integrin signaling.
Despite the above evidence, a unifying physiological role
for a protein^protein interaction mediated by the PH domain
has not been identi¢ed and in the majority of instances such
an interaction alone seems unlikely to drive an e⁄cient re-
cruitment of the host protein to the membrane. Taken togeth-
er, these observations lead us to the conclusion that, in several
cases, PH domain binding to a protein may not be su⁄cient
to target the host protein to the plasma membrane but it may
be important to stabilise interactions mediated by other com-
ponents (see below).
3. PH domain as a phospholipid binding domain
Most PH domains bind to phosphoinositides or inositol
phosphates. The ¢rst evidence was provided by Harlan et al.
[15] who demonstrated that the PH domains from pleckstrin
and several other proteins could bind to lipid vesicles contain-
ing the phosphoinositide phosphatidylinositol 4,5-bisphos-
phate (PtdIns-4,5-P2). Polyphosphoinositides represent diverse
membrane targeting sites for PH domains because they in-
clude lipids that are produced in response to activation of
Fig. 1. Ribbon diagram of the phospholipase CN PH domain in complex with inositol 3,4,5-trisphosphate.
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cell surface receptors. Examples include the products of the
phosphoinositide 3-kinase (PI 3-K), and lipids that are present
in cells constitutively and in high abundance, such as the
PtdIns-4,5-P2 [16]. When membrane localisation is mediated
by PtdIns-4,5-P2, there is a less stringent requirement for high
a⁄nity and speci¢city, since this phosphoinositide is much
more abundant than PI 3-K products, even in stimulated cells.
Indeed, PH domains bind phosphoinositides with a broad
range of speci¢city and a⁄nity; a clear stereospeci¢city and
high binding a⁄nity has been demonstrated only in a few
cases, with the majority of PH domains binding phosphoino-
sitides with low a⁄nity and speci¢city [17].
4. Classi¢cation
Several methods have been developed to analyse phospho-
lipid binding speci¢city of the PH domains [17^20] and di¡er-
ent classi¢cations have been proposed [17,21,22]. In the fol-
lowing, we propose a classi¢cation based on a comparative
analysis of these studies (Table 1). In the ¢rst group, we in-
clude PH domains that bind with high a⁄nity to a speci¢c
phosphoinositide, such as that of phospholipase C (PLC)-N1
which binds PtdIns-4,5-P2, those of Btk and general receptor
for 3-phosphoinositides (Grp1), which bind phosphatidylino-
sitol-3,4,5-trisphosphate (PtdIns-3,4,5-P3). For these the inter-
action is su⁄cient to target the host protein to the plasma
membrane. The second group includes PH domains that
show a low speci¢city and/or a⁄nity, such as those of the
Grb-2-associated protein 1 (Gab1), Dbl, IRS-1, PLC-Q and
PLC-L and, more important, that are unlikely to be su⁄cient
to drive a translocation of the host protein to the plasma
membrane. Finally, the third group includes PH domains,
such as those of pleckstrin, diacylglycerol kinase-N (DAG
K-N) and dynamin, that bind non-speci¢cally to phosphoino-
sitides.
5. Strong interactions between PH domains and
phosphoinositides (group 1)
The molecular basis for strong binding of the members of
group 1 to a speci¢c phosphoinositide, as well as the physio-
logical function of such an interaction, has been clari¢ed in
several cases.
The ¢rst PH domain showing a speci¢c phosphoinositide
ligand was identi¢ed at the N-terminus of PLC-N1. This PH
domain binds strongly and speci¢cally to both PtdIns-4,5-P2
and its soluble headgroup inositol-1,4,5-trisphosphate (Ins-
1,4,5-P3) [23,24]. The X-ray crystal structure of the isolated
PH domain, complexed with Ins-1,4,5-P3, has shown that
binding occurs to the surface of the PH domain de¢ned by
the variable loops 1^3 and is stabilised by direct hydrogen
bonding between the 4- and 5-phosphates and the side chains
of amino acids in these loops [25]. This strong interaction is
su⁄cient to target the host protein to the surface of the plas-
ma membrane in mammalian cells where its substrate, PtdIns-
4,5-P2, is located, allowing processive hydrolysis of the sub-
strate molecules.
Analogously, binding of the PH domain of Btk to PtdIns-
3,4,5-P3 re-localises this protein from the cytosol to the plas-
ma membrane [26] and this targeting facilitates the phosphor-
ylation and activation of Btk by Src family tyrosine kinases
[27]. Btk speci¢cally binds the PtdIns-3,4,5-P3 headgroup;
binding to the PtdIns-4,5-P2 headgroup occurs with a⁄nity
100-fold less [28]. This is consistent with a PI 3-K-dependent
mechanism for localisation to the plasma membrane. A high-
resolution crystallographic structure of the R28C mutant of
the Btk PH domain has revealed that the putative phospho-
inositide binding site is formed by residues of loop 1 and
L-strands 1, 2, 3 and 4 [29].
The PH domain of the Arf exchange factor Grp1 shows a
high binding a⁄nity for PtdIns-3,4,5-P3 [20]. Indeed this pro-
tein was identi¢ed on the basis of its binding to PtdIns-3,4,5-
P3 in a cDNA expression library screen [30] and the plasma
membrane localisation of its PH domain is strongly enhanced
by introduction of a constitutively active PI 3-K catalytic sub-
unit into mammalian cells [17]. Thus this speci¢c, high-a⁄nity
binding is likely to be su⁄cient for signal-dependent mem-
brane recruitment mediated by PI 3-K products. This is con-
¢rmed by experiments in intact cells showing that the Grp1^
PH domain is both necessary and su⁄cient to target the full-
length protein to the plasma membrane after insulin stimula-
tion [31].
Recently, the crystal structures of Btk PH domain in com-
plex with D-myo-inositol-1,3,4,5-tetrakisphosphate (D-myo-
Ins-1,3,4,5-P4) [32] and of Grp1 PH domain bound to Ins-
1,3,4,5-P4 [33,34] have been determined, revealing the details
of their speci¢city and high a⁄nity. In particular, the struc-
tural studies of Btk PH domain have shown that the 3-, 4- and
5-phosphates may interact with the side chains of two acidic
residues on one side and with the backbone of the L1/L2 loop
on the other side. This high number of contacts is su⁄cient to
guarantee a stable interaction and accounts for the high a⁄n-
ity and speci¢city of the Btk PH domain for Ins-1,3,4,5-P4
over Ins-1,4,5-P3 [32]. Crystal analyses of the Grp1 PH do-
Table 1
PH domain classi¢cation
PH domain Phosphoinositides References
Group 1 Btk PtdIns-3,4,5-P3EPIs [28]
PLC-N1 PtdIns-4,5-P2EPIs [20,23,24]
Grp1 PtdIns-3,4,5-P3EPIs [20,30]
Group 2 PLC-L1 PtdIns-3-PsPtdIns-3,4,5-P3, PtdIns-4,5-P2 [36]
Dbl PtdIns-4,5-P2, PtdIns-3,4,5-P3 [39]
Gab1 PtdIns-3,4,5-P3sPtdIns-4,5-P2, PtdIns-3,4-P2 [41]
IRS-1 PtdIns-3,4,5-P3sPtdIns-4,5-P2, PtdIns-3,4-P2 [20]
PLC-Q1 PtdIns-3,4,5-P3sPtdIns-3-P, PtdIns-4,5-P2 [19]
Group 3 Pleckstrin non-speci¢c [17,36,49]
Dynamin non-speci¢c [21,24,25,36]
DAG K-N non-speci¢c [17,49]
This classi¢cation is based on phosphoinositide binding a⁄nity and selectivity.
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main in an unligated form or in complex with Ins-1,3,4,5-P4
have revealed the presence of a 20-residue insertion within the
L6/L7 loop. This insertion, which adopts a twisted L-hairpin
structure and extends the L-barrel from seven to nine strands,
has been proposed to account for the ability of the Grp1 PH
domain to selectively bind PtdIns-3,4,5-P3 but not PtdIns-3,4-
P2 or PtdIns-4,5-P2 with high a⁄nity [33]. The high speci¢city
of Grp1 PH domain has been further con¢rmed by an anal-
ysis of its crystal structure, in complex with Ins-1,3,4,5-P4,
showing that this PH domain is able to make two unique
hydrogen bonds to the 5-phosphate [34]. All these PH do-
mains share a general mechanism for recruitment of proteins
to the plasma membrane involving either a constitutive or a
signal-dependent presence of a speci¢c lipid molecule in the
plasma membrane to which the proteins can bind via their PH
domains.
6. Weak and promiscuous interactions between PH domains
and phosphoinositides (group 2)
Only a limited subset of PH domains can be included in the
¢rst group, since the majority of PH domains bind phospho-
inositides with a low speci¢city and/or a low a⁄nity. Low
speci¢city leads essentially to a ‘promiscuous’ PH domain
that is a PH domain that binds several phosphoinositides
with similar a⁄nities.
Low a⁄nity essentially means ‘weak’ PH domains, those
that have an inherent a⁄nity for the membrane surface, which
is insu⁄cient to drive the membrane localisation of the pro-
tein. Many di¡erent mechanisms have been suggested that
would overcome this. We focused our attention on two hy-
potheses. The ¢rst hypothesis suggests that a weak PH^phos-
phoinositide interaction could be stabilised by a co-operative
binding with a protein within the same PH domain (Fig. 2A).
A second possibility is that PH domains may act simultane-
ously with other domains of the protein to achieve a stable
recruitment of the host protein to the plasma membrane (Fig.
2B).
6.1. Lipid^protein co-operative mechanism within the same
PH domain
This mechanism has been ¢rst proposed for the PH domain
of L-ARK. In fact, the PH domain of L-ARK has been shown
to interact with both GLQ and PtdIns-4,5-P2 at the carboxy-
and amino-termini, respectively [6,15]. The simultaneous in-
teraction of these two PH domain ligands is required for
e¡ective membrane association and activation of L-ARK.
Neither PH domain binding ligand alone is su⁄cient to a¡ect
this functional activation of the enzyme [35]. The evidence
that GLQ and PtdIns-4,5-P2 bind to di¡erent parts of the
PH domain suggests a co-operative, and not a competitive,
mechanism (Fig. 2A).
We recently suggested a similar putative double interaction
for the PH domain of PLC-L1 [36]. The PH domain of this
protein binds to phosphatidylinositol 3-phosphate (PtdIns-3-
P), while interacting more weakly with PtdIns-4,5-P2 and
PtdIns-3,4,5-P3. Accordingly, it undergoes a rapid, but tran-
sient, migration to the plasma membrane upon stimulation of
cells with serum or lysophosphatidic acid and this is inhibited
by pretreatment with PI 3-K inhibitors. These results indicate
that the PH domain can target the PLC-L1 to the plasma
membrane by binding to the PtdIns-3-P. However, previous
studies have already indicated that this PH domain may also
bind to the GLQ subunits, thus providing a further means to
Fig. 2. Model outlining the role of PH domain interactions in membrane recruitment of PH domain-containing protein. A: Lipid^protein co-
operative mechanism within the L-ARK PH domain. B: Membrane recruitment of Gab1 through the concerted action of PH and MBD do-
mains.
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anchor the protein to the plasma membrane [37]. Consistent
with this observation, it has been shown that the isolated PH
domain of PLC-L1, fused to the green £uorescent protein, can
be recruited to the plasma membrane also in unstimulated
cells if microinjected with the GLQ subunits [36]. Taken to-
gether, these data seem to indicate that localisation and acti-
vation of PLC-L1, mediated by PH domain, is regulated by a
co-operative mechanism involving PtdIns-3-P as well as GLQ
subunits.
A putative double interaction is likely to occur also in the
case of the Dbl PH domain [38]. This PH domain binds to
both PtdIns-4,5-P2 and PtdIns-3,4,5-P3, and it has been
shown that three positively charged amino acids located in
the L1/L2 loop mediate this interaction. It is noteworthy
that the wild-type PH domain localises both to the plasma
membrane and to actin stress ¢bres while Dbl mutants, unable
to bind the phosphoinositides, fail to localise to the plasma
membrane but still co-localise with actin. This is consistent
with the observation that this PH domain is necessary and
su⁄cient for the association of Dbl with the Triton X-100-
insoluble cytoskeletal components [39]. These ¢ndings suggest
that PH domain localisation to plasma membrane and actin
stress ¢bres may be mediated by di¡erent residues in its PH
domain [38].
6.2. ‘Tandem domain’ co-operative binding
A ‘tandem model’ has been proposed as potential mecha-
nism that stabilises a weak interaction of PH domain through
a co-operation with other domains of the host protein. This
model has been proposed for the components of the so-called
Grp1 family proteins, ARNO and cytohesin-1 [31]. A similar
model has been proposed for the endothelial growth factor
(EGF)-induced recruitment of the docking protein Gab1.
The Gab1 PH domain has been found to bind PtdIns-3,4,5-
P3 and to a lesser extent PtdIns-3-P, PtdIns-3,4-P2 and
PtdIns-4,5-P2 [40]. Signi¢cantly, the L1/L2 loop of this domain
shows strong sequence identity with PH domains of other
proteins known to bind PI 3-K products. Considerable evi-
dence supports a critical role for the PH domain and a re-
quirement for PI 3-K in the translocation of Gab1 to the
plasma membrane [18,40,41]. The PH domain is likely to act
co-operatively with another domain, the so-called Met bind-
ing domain (MBD), whose role on binding to the receptor has
been previously emphasised [42]. Since the binding of MBD to
the EGF receptor is relatively weak, concerted action of both
domains may be required to achieve stable membrane recruit-
ment of Gab1 of su⁄cient duration to enhance its tyrosine
phosphorylation and association with downstream signaling
molecules (Fig. 2B) [40].
A similar mechanism has been proposed for PLC-Q. It is
clear that, upon growth factor stimulation, the SH2 domains
of PLC-Q bind to tyrosine-autophosphorylated sites in growth
factor receptors, leading to tyrosine phosphorylation and
stimulation of PLC-Q activity [43]. In this model, receptor ty-
rosine kinases function as docking sites, providing one mech-
anism for targeting the enzyme to the cell surface. Other stud-
ies have shown that the PLC-Q PH domain binds to PtdIns-
3,4,5-P3 and is targeted to the plasma membrane in a PI 3-K-
dependent manner [19]. These data indicate that PLC-Q tar-
geting to the plasma membrane is the result of a synergistic
action of the SH2 domains (mediating the association to the
receptor) with the PH domain; it could stabilise the interac-
tion by binding to the membrane via PtdIns-3,4,5-P3. In par-
ticular, a model was proposed in which plasma-derived
growth factor-induced generation of PtdIns-3,4,5-P3 leads to
translocation of PLC-Q to the plasma membrane, a step that
increases the local concentration of the enzyme in the vicinity
of its substrate, PtdIns-4,5-P2, probably leading to more e⁄-
cient substrate hydrolysis [19,43]. Recent work demonstrates
that all determinants required for the association of PLC-Q to
the EGF receptor are found within a region unique for the
PLC-Q family. Furthermore, the association of PLC-Q to the
EGF receptor is una¡ected by mutations in the PH domain or
inhibition of PI 3-K, thus indicating that the PH domain-
mediated translocation does not contribute to the stability
of the complex [44]. In addition, PH domain-mediated trans-
location occurs later, compared to receptor translocation, thus
excluding the possibility that it could precede the interaction
with the receptor. This ¢nding suggests that the PH domain
may not play a role in the initial translocation to the EGF
receptor indicating that it could be important for some other
steps involved in the stimulation of PLC-Q [44].
Finally, both mechanisms have been proposed for the PH
domain of IRS-1. In addition to the speci¢c protein binding
discussed above [11,12], the PH domain of IRS-1 has been
reported to bind phosphoinositides and the latter property is
required for IRS-1 function [20,45,46]. In particular, PtdIns-
3,4,5-P3 and PtdIns-4,5-P2 bind with almost the same a⁄nity
[45] although a preferential binding to PtdIns-3,4,5-P3 is likely
to occur [20]. PtdIns-3,4-P2 and PtdIns-4-P show four- to
eight-fold lower a⁄nity [20,45]. It could be hypothesised
that a protein and a phosphoinositide can bind to di¡erent
residues within the same PH domain, thus acting co-opera-
tively to localise the protein and having a speci¢c role in the
membrane compartmentalisation of IRS-1. Alternatively, a
co-operation with another domain of the protein has been
proposed [45]. In IRS-1, PH domain is £anked immediately
downstream by a phosphotyrosine binding (PTB) domain.
The crystal structure of the region of IRS-1 containing both
these domains has been determined, showing that they both
adopt the conserved PH fold and they are closely associated
such that the front sheet of the PH domain is against the back
of the PTB domain. However, despite their similar overall
structure and close interaction, mediated by a series of hydro-
gen bonds, their binding speci¢cities remain quite distinct.
Direct assays demonstrate that phosphatidylinositides bind
the PH but not the PTB domain that in its turn binds to
phosphotyrosines in the motif found near the transmembrane
region of the insulin receptor. It is noteworthy that binding to
either domain does not alter the binding properties of the
other, indicating that the two binding domains can act co-
operatively to localise the protein at the membrane [45]. Con-
sistent with this hypothesis, many reports indicate that both
the PTB domain and the PH domain are required for e⁄cient
tyrosine phosphorylation of IRS-1 in response to insulin stim-
ulation [47,48].
7. Non-speci¢c interactions between PH domains and
phosphoinositides (group 3)
Several PH domains appear quite non-speci¢c in their phos-
pholipid binding. Studies of binding to small unilamellar
vesicles containing di¡erent combinations of phospholipids
have shown that the N-terminal PH domain of pleckstrin-1
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can bind phosphatidylserine as well as phosphoinositides [17].
A comparison of phosphoinositide binding speci¢city using a
dot-blot screen has shown that also the DAG K-N PH domain
gives a signi¢cant signal with phosphatidylserine [17]. These
data have suggested that these PH domains simply recognise a
negatively charged surface and not any particular character-
istic of the inositol phosphate headgroup. Consistent with
these results, studies of inositol phosphate binding to the
pleckstrin-1 and DAG K-N PH domains have demonstrated
that there is no stereospeci¢city and that a⁄nity correlates
most strongly with the number of phosphate groups [49].
The non-speci¢c interaction of the pleckstrin PH domain
has also been con¢rmed by [3H]inositol binding analysed by
anion exchange HPLC [36].
Although it has been reported that the isolated PH domain
of dynamin-1 speci¢cally interacts with liposomes containing
PtdIns-4,5-P2 [28], other studies have been unable to detect
signi¢cant binding of this PH domain to phosphoinositides
[21,24,25,36]. It has been demonstrated that the PH domains
from two mammalian dynamin isoforms require their oligo-
merisation for high-a⁄nity phosphoinositide binding [50].
Since the capability of dynamin to form tetramers and high-
er-order assemblies is critical for its physiological function, it
has been suggested that the PH domain-mediated binding of
dynamin to phosphoinositide-containing membranes requires
its self-assembly. This hypothesis raises the possibility that
alternative mechanisms to those presented in this review
may actually exist to overcome the problem of a low a⁄nity
and/or speci¢city of the PH domains.
8. Concluding remarks
Although the functional role has been elucidated for a few
PH domains, for the majority it remains elusive. The potential
synergy of two di¡erent ligands, a lipid and a protein, may
shed light on the function of PH domain in several proteins
that contain this structural domain. This raises the possibility
that two di¡erent steps may regulate the signaling pathways
involving a PH domain protein. This gives a higher speci¢city
to both membrane binding and intracellular targeting medi-
ated by the PH domain. It is an important challenge to iden-
tify speci¢c methods that will enable lipid^protein synergistic
binding to be studied.
Acknowledgements: We would like to thank Prof. M.A. Horton for
critical reading of the manuscript. M.F. is supported by an endow-
ment from the Dr Mortimer and Mrs Theresa Sackler Trust. Publi-
cation (1) from the Sackler Institute for Muscular Skeletal Research,
UCL.
References
[1] Haslam, R.J., Koide, H.B. and Hemmings, B.A. (1993) Nature
363, 309^310.
[2] Mayer, B.J., Ren, R., Clark, K.L. and Baltimore, D. (1993) Cell
73, 629^630.
[3] Lemmon, M.A. and Ferguson, K.M. (1998) Curr. Topics Micro-
biol. Immunol. 228, 39^74.
[4] Rebecchi, M.J. and Scarlata, S. (1998) Annu. Rev. Biophys. Bio-
mol. Struct. 27, 503^528.
[5] Gibson, T.J., Hyvo«nen, M., Musacchio, A., Saraste, M. and
Birney, E. (1994) Trends Biochem. Sci. 19, 349^353.
[6] Touhara, K., Inglese, J., Pitcher, J.A., Shaw, G. and Lefkowitz,
R.J. (1994) J. Biol. Chem. 269, 10217^10220.
[7] Tsukada, S., Simon, M.I., Witte, O.N. and Katz, A. (1994) Proc.
Natl. Acad. Sci. USA 91, 11256^11260.
[8] Wang, D.-S., Shaw, R., Winkelmann, J.C. and Shaw, G. (1994)
Biochem. Biophys. Res. Commun. 203, 29^35.
[9] Touhara, K., Koch, W.J., Hawes, B.E. and Lefkowitz, R.J.
(1995) J. Biol. Chem. 270, 17000^17005.
[10] Wang, D.-S., Shaw, R., Hattori, M., Arai, H., Inoue, K. and
Shaw, G. (1995) Biochem. Biophys. Res. Commun. 209, 622^629.
[11] Burks, D.J., Wang, J., Towery, H., Ishibashi, O., Lowe, D.,
Riedel, H. and White, M.F. (1998) J. Biol. Chem. 273, 31061^
31067.
[12] Farhang-Fallah, J., Yin, X., Trentin, G., Cheng, A.M. and Ro-
zakis-Adcock, M. (2000) J. Biol. Chem. 275, 40492^40497.
[13] Yao, L., Janmey, P., Frigeri, L.G., Han, W., Fujita, J., Kawa-
kami, Y., Apgar, J.R. and Kawakami, T. (1999) J. Biol. Chem.
274, 19752^19761.
[14] Chen, R., Kim, O., Li, M., Xiong, X., Guan, J.-L., Kung, H.-J.,
Chen, H., Shimizu, Y. and Qiu, Y. (2001) Nature Cell Biol. 3,
439^444.
[15] Harlan, J.E., Hajduk, P.J., Yoon, H.S. and Fesik, S.W. (1994)
Nature 317, 168^170.
[16] Lemmon, M.A., Falasca, M., Ferguson, K.M. and Schlessinger,
J. (1997) Trends Cell Biol. 7, 237^242.
[17] Kavran, J.M., Klein, D.E., Lee, A., Falasca, M., Isako¡, S.J.,
Skolnik, E.Y. and Lemmon, M.A. (1998) J. Biol. Chem. 273,
30497^30508.
[18] Isako¡, S.J., Cardozo, T., Andreev, J., Li, Z., Ferguson, K.M.,
Abagyan, R., Lemmon, M.A., Aronheim, A. and Skolnik, E.Y.
(1998) EMBO J. 17, 5374^5387.
[19] Falasca, M., Logan, S.K., Lehto, V.P., Baccante, G., Lemmon,
M.A. and Schlessinger, J. (1998) EMBO J. 17, 414^422.
[20] Razzini, G., Ingrosso, A., Brancaccio, A., Sciacchitano, S., Es-
posito, D.L. and Falasca, M. (2000) Mol. Endocrinol. 14, 823^
836.
[21] Rameh, L.E., Arvidsson, A.-K., Carraway III, K.L., Couvillon,
A.D., Rathbun, G., Crompton, A., VanRenterghem, B., Czech,
M.P., Ravichandran, K.S., Burako¡, S.J., Wang, D.-S., Chen,
C.-S. and Cantley, L.C. (1997) J. Biol. Chem. 272, 22059^22066.
[22] Hurley, J.H. and Misra, S. (2000) Annu. Rev. Biophys. Biomol.
Struct. 29, 49^79.
[23] Garcia, P., Gupta, R., Shah, S., Morris, A.J., Rudge, S.A., Scar-
lata, S., Petrova, V., McLaughlin, L. and Rebecchi, M.J. (1995)
Biochemistry 34, 16228^16234.
[24] Lemmon, M.A., Ferguson, K.M., O’Brien, R., Sigler, P.B. and
Schlessinger, J. (1995) Proc. Natl. Acad. Sci. USA 92, 10472^
10476.
[25] Ferguson, K.M., Lemmon, M.A., Schlessinger, J. and Sigler, P.B.
(1995) Cell 83, 1037^1046.
[26] Varnai, P., Rother, K.I. and Balla, T. (1999) J. Biol. Chem. 274,
10983^10989.
[27] Saito, K., Scharenberg, A.M. and Kinet, J.-P. (2001) J. Biol.
Chem. 276, 16201^16206.
[28] Salim, K., Bottomley, M.J., Querfurth, E., Zvelebil, M.J., Gout,
I., Scaife, R., Margolis, R.L., Gigg, R., Smith, C.I., Driscoll,
P.C., Water¢eld, M.D. and Panayotou, G. (1996) EMBO J. 15,
6241^6250.
[29] Hyvo«nen, M. and Saraste, M. (1997) EMBO J. 16, 3396^3404.
[30] Klarlund, J.K., Guilherme, A., Holik, J.J., Virbasius, J.V., Chaw-
la, A. and Czech, M.P. (1997) Science 275, 1927^1930.
[31] Klarlund, J.K., Tsiaras, W., Holik, J.J., Chawla, A. and Czech,
M.P. (2000) J. Biol. Chem. 275, 32816^32821.
[32] Baraldi, E., Djinovic Carugo, K., Hyvo«nen, M., Lo Surdo, P.,
Riley, A.M., Potter, B.V.L., O’Brien, R., Ladbury, J.E. and
Saraste, M. (1999) Structure 7, 449^460.
[33] Lietzke, S.E., Bose, S., Cronin, T., Klarlund, J., Chawla, A.,
Czech, M.P. and Lambright, D.G. (2000) Mol. Cell 6, 385^394.
[34] Ferguson, K.M., Kavran, J.M., Sankaran, V.G., Fournier, E.,
Isako¡, S.J., Skolnik, E.Y. and Lemmon, M.A. (2000) Mol.
Cell 6, 373^384.
[35] Pitcher, J.A., Touhara, K., Payne, E.S. and Lefkowitz, R.J.
(1995) J. Biol. Chem. 270, 11707^11710.
[36] Razzini, G., Brancaccio, A., Lemmon, M.A., Guarnieri, S. and
Falasca, M. (2000) J. Biol. Chem. 275, 14873^14881.
[37] Wang, T., Pentyala, S., Rebecchi, M.J. and Scarlata, S. (1999)
Biochemistry 38, 1517^1524.
FEBS 25306 5-10-01 Cyaan Magenta Geel Zwart
T. Ma¡ucci, M. Falasca/FEBS Letters 506 (2001) 173^179178
[38] Russo, C., Gao, Y., Mancini, P., Vanni, C., Porotto, M., Falas-
ca, M., Torrisi, M.R., Zheng, Y. and Eva, A. (2001) J. Biol.
Chem. 276, 19524^19531.
[39] Zheng, Y., Zangrilli, D., Cerione, R.A. and Eva, A. (1996)
J. Biol. Chem. 271, 19017^19020.
[40] Rodrigues, G.A., Falasca, M., Zhang, Z., Ong, S.H. and Schles-
singer, J. (2000) Mol. Cell. Biol. 20, 1448^1459.
[41] Maroun, C.R., Holgado-Madruga, M., Royal, I., Naujokas,
M.A., Fournier, T.M., Wong, A.J. and Park, M. (1999) Mol.
Cell. Biol. 19, 1784^1799.
[42] Weidner, K.M., Di Cesare, S., Sachs, M., Brinkmann, V., Beh-
rens, J. and Birchmeier, W. (1996) Nature 384, 173^176.
[43] Schlessinger, J. (2000) Cell 103, 211^225.
[44] Matsuda, M., Paterson, H.F., Rodriguez, R., Fensome, A.C.,
Ellis, M.V., Swann, K. and Katan, M. (2001) J. Cell Biol. 153,
599^612.
[45] Dhe-Paganon, S., Ottinger, E.A., Nolte, R.T., Eck, M.J. and
Shoelson, S.E. (1999) Proc. Natl. Acad. Sci. USA 96, 8378^
8383.
[46] Vainshtein, I., Kovacina, K.S. and Roth, R.A. (2001) J. Biol.
Chem. 276, 8073^8078.
[47] Myers Jr., M.G., Grammer, T.C., Brooks, J., Glasheen, E.M.,
Wang, L.M., Sun, X.J., Blenis, J., Pierce, J.H. and White, M.F.
(1995) J. Biol. Chem. 270, 11715^11718.
[48] Yenush, L., Makati, K.J., Smith-Hall, J., Ishibashi, O., Myers
Jr., M.G. and White, M.F. (1996) J. Biol. Chem. 271, 24300^
24306.
[49] Takeuchi, H., Kanematsu, T., Misumi, Y., Sakane, F., Konishi,
H., Kikkawa, U., Watanabe, Y., Katan, M. and Hirata, M.
(1997) Biochim. Biophys. Acta 1359, 275^285.
[50] Klein, D.E., Lee, A., Frank, D.W., Marks, M.S. and Lemmon,
M.A. (1998) J. Biol. Chem. 273, 27725^27733.
FEBS 25306 5-10-01 Cyaan Magenta Geel Zwart
T. Ma¡ucci, M. Falasca/FEBS Letters 506 (2001) 173^179 179
